APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bone, Muscle and Joint Supplement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bone, Muscle and Joint Supplement Market Outlook and Growth Opportunities 2026

30 December 2025191 pages

Choose your research edition.

Industry ResearchBone, Muscle and Joint Supplement Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Bone, Muscle and Joint Supplement Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Bone, Muscle and Joint Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bone, Muscle and Joint Supplement Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bone, Muscle and Joint Supplement Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bone, Muscle and Joint Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bone, Muscle and Joint Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bone, Muscle and Joint Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bone, Muscle and Joint Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bone, Muscle and Joint Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bone, Muscle and Joint Supplement market include allók, BetterYou, DR.VEGAN, Holland & Barrett, Neocell, Puressentiel, Revive Collagen, Solgar and Vitabiotics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bone, Muscle and Joint Supplement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bone, Muscle and Joint Supplement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bone, Muscle and Joint Supplement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bone, Muscle and Joint Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.

Bone, Muscle and Joint Supplement Segment by Company

allók

BetterYou

DR.VEGAN

Holland & Barrett

Neocell

Puressentiel

Revive Collagen

Solgar

Vitabiotics

Vital Proteins

Weleda

Bone, Muscle and Joint Supplement Segment by Type

Tablets

Capsules

Bone, Muscle and Joint Supplement Segment by Application

Online Pharmacies

Retail Pharmacies

Hospital

Bone, Muscle and Joint Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bone, Muscle and Joint Supplement status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bone, Muscle and Joint Supplement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bone, Muscle and Joint Supplement significant trends, drivers, influence factors in global and regions.

6. To analyze Bone, Muscle and Joint Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone, Muscle and Joint Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bone, Muscle and Joint Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone, Muscle and Joint Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bone, Muscle and Joint Supplement market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bone, Muscle and Joint Supplement industry.

Chapter 3: Detailed analysis of Bone, Muscle and Joint Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bone, Muscle and Joint Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bone, Muscle and Joint Supplement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bone, Muscle and Joint Supplement Industry Trends Table 2. Bone, Muscle and Joint Supplement Industry Drivers Table 3. Bone, Muscle and Joint Supplement Industry Opportunities and Challenges Table 4. Bone, Muscle and Joint Supplement Industry Restraints Table 5. Global Bone, Muscle and Joint Supplement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bone, Muscle and Joint Supplement Revenue Share by Company (2021-2026) Table 7. Global Bone, Muscle and Joint Supplement Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Bone, Muscle and Joint Supplement Sales Volume Share by Company (2021-2026) Table 9. Global Bone, Muscle and Joint Supplement Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bone, Muscle and Joint Supplement Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bone, Muscle and Joint Supplement Key Company Manufacturing Base & Headquarters Table 12. Global Bone, Muscle and Joint Supplement Company, Product Type & Application Table 13. Global Bone, Muscle and Joint Supplement Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bone, Muscle and Joint Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Bone, Muscle and Joint Supplement Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Bone, Muscle and Joint Supplement Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Bone, Muscle and Joint Supplement Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Bone, Muscle and Joint Supplement Sales Volume Share by Type (2021-2026) Table 23. Global Bone, Muscle and Joint Supplement Sales Volume Share by Type (2027-2032) Table 24. Global Bone, Muscle and Joint Supplement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bone, Muscle and Joint Supplement Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bone, Muscle and Joint Supplement Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bone, Muscle and Joint Supplement Sales Value Share by Type (2021-2026) Table 28. Global Bone, Muscle and Joint Supplement Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Pharmacies Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Hospital Table 32. Global Bone, Muscle and Joint Supplement Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Bone, Muscle and Joint Supplement Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Bone, Muscle and Joint Supplement Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Bone, Muscle and Joint Supplement Sales Volume Share by Application (2021-2026) Table 36. Global Bone, Muscle and Joint Supplement Sales Volume Share by Application (2027-2032) Table 37. Global Bone, Muscle and Joint Supplement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bone, Muscle and Joint Supplement Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bone, Muscle and Joint Supplement Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bone, Muscle and Joint Supplement Sales Value Share by Application (2021-2026) Table 41. Global Bone, Muscle and Joint Supplement Sales Value Share by Application (2027-2032) Table 42. Global Bone, Muscle and Joint Supplement Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Bone, Muscle and Joint Supplement Sales by Region (2021-2026) & (K Units) Table 44. Global Bone, Muscle and Joint Supplement Sales Market Share by Region (2021-2026) Table 45. Global Bone, Muscle and Joint Supplement Sales by Region (2027-2032) & (K Units) Table 46. Global Bone, Muscle and Joint Supplement Sales Market Share by Region (2027-2032) Table 47. Global Bone, Muscle and Joint Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bone, Muscle and Joint Supplement Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bone, Muscle and Joint Supplement Sales Value Share by Region (2021-2026) Table 50. Global Bone, Muscle and Joint Supplement Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bone, Muscle and Joint Supplement Sales Value Share by Region (2027-2032) Table 52. Global Bone, Muscle and Joint Supplement Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bone, Muscle and Joint Supplement Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bone, Muscle and Joint Supplement Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Bone, Muscle and Joint Supplement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bone, Muscle and Joint Supplement Sales by Country (2021-2026) & (K Units) Table 57. Global Bone, Muscle and Joint Supplement Sales Market Share by Country (2021-2026) Table 58. Global Bone, Muscle and Joint Supplement Sales by Country (2027-2032) & (K Units) Table 59. Global Bone, Muscle and Joint Supplement Sales Market Share by Country (2027-2032) Table 60. Global Bone, Muscle and Joint Supplement Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bone, Muscle and Joint Supplement Sales Value Market Share by Country (2021-2026) Table 62. Global Bone, Muscle and Joint Supplement Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bone, Muscle and Joint Supplement Sales Value Market Share by Country (2027-2032) Table 64. allók Company Information Table 65. allók Business Overview Table 66. allók Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. allók Bone, Muscle and Joint Supplement Product Portfolio Table 68. allók Recent Development Table 69. BetterYou Company Information Table 70. BetterYou Business Overview Table 71. BetterYou Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. BetterYou Bone, Muscle and Joint Supplement Product Portfolio Table 73. BetterYou Recent Development Table 74. DR.VEGAN Company Information Table 75. DR.VEGAN Business Overview Table 76. DR.VEGAN Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. DR.VEGAN Bone, Muscle and Joint Supplement Product Portfolio Table 78. DR.VEGAN Recent Development Table 79. Holland & Barrett Company Information Table 80. Holland & Barrett Business Overview Table 81. Holland & Barrett Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Holland & Barrett Bone, Muscle and Joint Supplement Product Portfolio Table 83. Holland & Barrett Recent Development Table 84. Neocell Company Information Table 85. Neocell Business Overview Table 86. Neocell Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Neocell Bone, Muscle and Joint Supplement Product Portfolio Table 88. Neocell Recent Development Table 89. Puressentiel Company Information Table 90. Puressentiel Business Overview Table 91. Puressentiel Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Puressentiel Bone, Muscle and Joint Supplement Product Portfolio Table 93. Puressentiel Recent Development Table 94. Revive Collagen Company Information Table 95. Revive Collagen Business Overview Table 96. Revive Collagen Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Revive Collagen Bone, Muscle and Joint Supplement Product Portfolio Table 98. Revive Collagen Recent Development Table 99. Solgar Company Information Table 100. Solgar Business Overview Table 101. Solgar Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Solgar Bone, Muscle and Joint Supplement Product Portfolio Table 103. Solgar Recent Development Table 104. Vitabiotics Company Information Table 105. Vitabiotics Business Overview Table 106. Vitabiotics Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Vitabiotics Bone, Muscle and Joint Supplement Product Portfolio Table 108. Vitabiotics Recent Development Table 109. Vital Proteins Company Information Table 110. Vital Proteins Business Overview Table 111. Vital Proteins Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Vital Proteins Bone, Muscle and Joint Supplement Product Portfolio Table 113. Vital Proteins Recent Development Table 114. Weleda Company Information Table 115. Weleda Business Overview Table 116. Weleda Bone, Muscle and Joint Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Weleda Bone, Muscle and Joint Supplement Product Portfolio Table 118. Weleda Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Bone, Muscle and Joint Supplement Distributors List Table 122. Bone, Muscle and Joint Supplement Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Bone, Muscle and Joint Supplement Product Image Figure 2. Global Bone, Muscle and Joint Supplement Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bone, Muscle and Joint Supplement Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bone, Muscle and Joint Supplement Sales (2021-2032) & (K Units) Figure 5. Global Bone, Muscle and Joint Supplement Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bone, Muscle and Joint Supplement Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Bone, Muscle and Joint Supplement Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Bone, Muscle and Joint Supplement Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bone, Muscle and Joint Supplement Sales Volume Share by Type (2021-2032) Figure 14. Global Bone, Muscle and Joint Supplement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bone, Muscle and Joint Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bone, Muscle and Joint Supplement Sales Value Share by Type (2021-2032) Figure 17. Online Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Hospital Image Figure 20. Global Bone, Muscle and Joint Supplement Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Bone, Muscle and Joint Supplement Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bone, Muscle and Joint Supplement Sales Volume Share by Application (2021-2032) Figure 23. Global Bone, Muscle and Joint Supplement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bone, Muscle and Joint Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bone, Muscle and Joint Supplement Sales Value Share by Application (2021-2032) Figure 26. Global Bone, Muscle and Joint Supplement Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Bone, Muscle and Joint Supplement Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bone, Muscle and Joint Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bone, Muscle and Joint Supplement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bone, Muscle and Joint Supplement Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bone, Muscle and Joint Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bone, Muscle and Joint Supplement Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bone, Muscle and Joint Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bone, Muscle and Joint Supplement Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bone, Muscle and Joint Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bone, Muscle and Joint Supplement Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bone, Muscle and Joint Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bone, Muscle and Joint Supplement Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bone, Muscle and Joint Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bone, Muscle and Joint Supplement Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bone, Muscle and Joint Supplement Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital
Companies covered
  • allók
  • BetterYou
  • DR.VEGAN
  • Holland & Barrett
  • Neocell
  • Puressentiel
  • Revive Collagen
  • Solgar
  • Vitabiotics
  • Vital Proteins
  • Weleda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bone, Muscle and Joint Supplement Sales Value (2021-2032)
  4. 1.2.2 Global Bone, Muscle and Joint Supplement Sales Volume (2021-2032)
  5. 1.2.3 Global Bone, Muscle and Joint Supplement Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bone, Muscle and Joint Supplement Market Dynamics
  1. 2.1 Bone, Muscle and Joint Supplement Industry Trends
  2. 2.2 Bone, Muscle and Joint Supplement Industry Drivers
  3. 2.3 Bone, Muscle and Joint Supplement Industry Opportunities and Challenges
  4. 2.4 Bone, Muscle and Joint Supplement Industry Restraints
3 Bone, Muscle and Joint Supplement Market by Company
  1. 3.1 Global Bone, Muscle and Joint Supplement Company Revenue Ranking in 2025
  2. 3.2 Global Bone, Muscle and Joint Supplement Revenue by Company (2021-2026)
  3. 3.3 Global Bone, Muscle and Joint Supplement Sales Volume by Company (2021-2026)
  4. 3.4 Global Bone, Muscle and Joint Supplement Average Price by Company (2021-2026)
  5. 3.5 Global Bone, Muscle and Joint Supplement Company Ranking (2024-2026)
  6. 3.6 Global Bone, Muscle and Joint Supplement Company Manufacturing Base and Headquarters
  7. 3.7 Global Bone, Muscle and Joint Supplement Company Product Type and Application
  8. 3.8 Global Bone, Muscle and Joint Supplement Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bone, Muscle and Joint Supplement Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bone, Muscle and Joint Supplement Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bone, Muscle and Joint Supplement Market by Type
  1. 4.1 Bone, Muscle and Joint Supplement Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Bone, Muscle and Joint Supplement Sales Volume by Type
  5. 4.2.1 Global Bone, Muscle and Joint Supplement Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bone, Muscle and Joint Supplement Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bone, Muscle and Joint Supplement Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bone, Muscle and Joint Supplement Sales Value by Type
  9. 4.3.1 Global Bone, Muscle and Joint Supplement Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bone, Muscle and Joint Supplement Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bone, Muscle and Joint Supplement Sales Value Share by Type (2021-2032)
5 Bone, Muscle and Joint Supplement Market by Application
  1. 5.1 Bone, Muscle and Joint Supplement Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Hospital
  5. 5.2 Global Bone, Muscle and Joint Supplement Sales Volume by Application
  6. 5.2.1 Global Bone, Muscle and Joint Supplement Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bone, Muscle and Joint Supplement Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bone, Muscle and Joint Supplement Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bone, Muscle and Joint Supplement Sales Value by Application
  10. 5.3.1 Global Bone, Muscle and Joint Supplement Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bone, Muscle and Joint Supplement Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bone, Muscle and Joint Supplement Sales Value Share by Application (2021-2032)
6 Bone, Muscle and Joint Supplement Regional Sales and Value Analysis
  1. 6.1 Global Bone, Muscle and Joint Supplement Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bone, Muscle and Joint Supplement Sales by Region (2021-2032)
  3. 6.2.1 Global Bone, Muscle and Joint Supplement Sales by Region: 2021-2026
  4. 6.2.2 Global Bone, Muscle and Joint Supplement Sales by Region (2027-2032)
  5. 6.3 Global Bone, Muscle and Joint Supplement Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bone, Muscle and Joint Supplement Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bone, Muscle and Joint Supplement Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bone, Muscle and Joint Supplement Sales Value by Region (2027-2032)
  9. 6.5 Global Bone, Muscle and Joint Supplement Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bone, Muscle and Joint Supplement Sales Value (2021-2032)
  12. 6.6.2 North America Bone, Muscle and Joint Supplement Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bone, Muscle and Joint Supplement Sales Value (2021-2032)
  15. 6.7.2 Europe Bone, Muscle and Joint Supplement Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bone, Muscle and Joint Supplement Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bone, Muscle and Joint Supplement Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bone, Muscle and Joint Supplement Sales Value (2021-2032)
  21. 6.9.2 South America Bone, Muscle and Joint Supplement Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bone, Muscle and Joint Supplement Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bone, Muscle and Joint Supplement Sales Value Share by Country, 2025 VS 2032
7 Bone, Muscle and Joint Supplement Country-level Sales and Value Analysis
  1. 7.1 Global Bone, Muscle and Joint Supplement Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bone, Muscle and Joint Supplement Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bone, Muscle and Joint Supplement Sales by Country (2021-2032)
  4. 7.3.1 Global Bone, Muscle and Joint Supplement Sales by Country (2021-2026)
  5. 7.3.2 Global Bone, Muscle and Joint Supplement Sales by Country (2027-2032)
  6. 7.4 Global Bone, Muscle and Joint Supplement Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bone, Muscle and Joint Supplement Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bone, Muscle and Joint Supplement Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bone, Muscle and Joint Supplement Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bone, Muscle and Joint Supplement Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bone, Muscle and Joint Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 allók
  2. 8.1.1 allók Company Information
  3. 8.1.2 allók Business Overview
  4. 8.1.3 allók Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 allók Bone, Muscle and Joint Supplement Product Portfolio
  6. 8.1.5 allók Recent Developments
  7. 8.2 BetterYou
  8. 8.2.1 BetterYou Company Information
  9. 8.2.2 BetterYou Business Overview
  10. 8.2.3 BetterYou Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BetterYou Bone, Muscle and Joint Supplement Product Portfolio
  12. 8.2.5 BetterYou Recent Developments
  13. 8.3 DR.VEGAN
  14. 8.3.1 DR.VEGAN Company Information
  15. 8.3.2 DR.VEGAN Business Overview
  16. 8.3.3 DR.VEGAN Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 DR.VEGAN Bone, Muscle and Joint Supplement Product Portfolio
  18. 8.3.5 DR.VEGAN Recent Developments
  19. 8.4 Holland & Barrett
  20. 8.4.1 Holland & Barrett Company Information
  21. 8.4.2 Holland & Barrett Business Overview
  22. 8.4.3 Holland & Barrett Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Holland & Barrett Bone, Muscle and Joint Supplement Product Portfolio
  24. 8.4.5 Holland & Barrett Recent Developments
  25. 8.5 Neocell
  26. 8.5.1 Neocell Company Information
  27. 8.5.2 Neocell Business Overview
  28. 8.5.3 Neocell Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Neocell Bone, Muscle and Joint Supplement Product Portfolio
  30. 8.5.5 Neocell Recent Developments
  31. 8.6 Puressentiel
  32. 8.6.1 Puressentiel Company Information
  33. 8.6.2 Puressentiel Business Overview
  34. 8.6.3 Puressentiel Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Puressentiel Bone, Muscle and Joint Supplement Product Portfolio
  36. 8.6.5 Puressentiel Recent Developments
  37. 8.7 Revive Collagen
  38. 8.7.1 Revive Collagen Company Information
  39. 8.7.2 Revive Collagen Business Overview
  40. 8.7.3 Revive Collagen Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Revive Collagen Bone, Muscle and Joint Supplement Product Portfolio
  42. 8.7.5 Revive Collagen Recent Developments
  43. 8.8 Solgar
  44. 8.8.1 Solgar Company Information
  45. 8.8.2 Solgar Business Overview
  46. 8.8.3 Solgar Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Solgar Bone, Muscle and Joint Supplement Product Portfolio
  48. 8.8.5 Solgar Recent Developments
  49. 8.9 Vitabiotics
  50. 8.9.1 Vitabiotics Company Information
  51. 8.9.2 Vitabiotics Business Overview
  52. 8.9.3 Vitabiotics Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vitabiotics Bone, Muscle and Joint Supplement Product Portfolio
  54. 8.9.5 Vitabiotics Recent Developments
  55. 8.10 Vital Proteins
  56. 8.10.1 Vital Proteins Company Information
  57. 8.10.2 Vital Proteins Business Overview
  58. 8.10.3 Vital Proteins Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Vital Proteins Bone, Muscle and Joint Supplement Product Portfolio
  60. 8.10.5 Vital Proteins Recent Developments
  61. 8.11 Weleda
  62. 8.11.1 Weleda Company Information
  63. 8.11.2 Weleda Business Overview
  64. 8.11.3 Weleda Bone, Muscle and Joint Supplement Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Weleda Bone, Muscle and Joint Supplement Product Portfolio
  66. 8.11.5 Weleda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bone, Muscle and Joint Supplement Value Chain Analysis
  2. 9.1.1 Bone, Muscle and Joint Supplement Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bone, Muscle and Joint Supplement Sales Mode & Process
  6. 9.2 Bone, Muscle and Joint Supplement Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bone, Muscle and Joint Supplement Distributors
  9. 9.2.3 Bone, Muscle and Joint Supplement Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst